跳至主要内容
临床试验/NCT00046449
NCT00046449已完成3 期

Prevention of Seasonal Affective Disorder

GlaxoSmithKline56 个研究点 分布在 2 个国家开始时间: 2002年9月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
试验地点
56

研究概览

简要总结

A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • (Patient must meet these criteria in order to be eligible for this study.)
  • Patient has a history of Major Depressive Disorder (MDD) with a seasonal pattern.

排除标准

  • (Patient cannot meet these criteria in order to be eligible for this study.)
  • Patient has a current or past history of seizure disorder or brain injury.
  • Patient has a history or current diagnosis of anorexia nervousa or bulimia.
  • Patient has recurrent summer depression more frequently than winter depression.
  • Patient has primary diagnosis of panic disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD), acute distress disorder, bipolar II disorder or other psychotic disorders.
  • Patient has initiated psychotherapy within the last 3 months.

研究者

申办方类型
Industry

研究点 (56)

Loading locations...

相似试验

Prevention of Seasonal Affective Disorder | 临床试验